ISO-8859-1''CONSENSO%20resumen%20%20CON%20BIBLIOGRAF%CDA%20%20JUNIO%2017%20%20%5B1847999%5D

35. Eva M. Conceição1*, Linsey M. Utzinger2,3 & Emily M. Pisetsky. Eating Disorders and
Problematic Eating Behaviours Before and After Bariatric Surgery: Characterization, Assessment
and Association with Treatment Outcomes European Eating Disorders Review Special Issue:
Bariatric Surgery November 201523, (6): 417–425
36. Sarah Malik, M.D.a,c, James E. Mitchell, M.D.a,b,*, Scott Engel, Ph.D.a,b, Ross Crosby,
Ph.D.a,b, and Steve Wonderlich, .Psychopathology in Bariatric Surgery Candidates: A Review of
Studies Using Structured Diagnostic Interviews. Compr Psychiatry. 2014 February ; 55(2): 248–
259
37. Pendleton VR, Goodrick GK, Poston WS, Reeves RS, Foreyt JP: Exercise augments the
effects of cognitive-behavioral therapy in the treatment of binge eating. Int J Eat Disord 2002;
31:172–184
38. Jáuregui I. Los trastornos de la conducta alimentaria en el DSM-5. Trastornos de la conducta
alimentaria Revista Chilena de Neuropsiquiatria año 68, vol 52, suplemento N° 1, marzo 2014
39. Scheck C, Mahowald M. Review of Nocturnal Sleep – Related eating Disorders. Int J Eating
Disord 1994; 15:343-356)
40. Ellenberg, Clementina, Verdi, Beatriz, et al (2006). Síndrome de comedor nocturno: un nuevo
trastorno de la conducta alimentaria. Anales Venezolanos de Nutrición, 19(1), 32-3)
41. Birketveldt. GS, Sundsfjord J; Florholmen J. Hyphotalamic-pituitary –adrenal axis in the night
eating syndrome. Am J Physiol Endocrinol Metab . 2004; 282 (2): E366-E369
42. Georgina Botebol-Benhamou,* María Aguilar-Andújar,* Rocío Díaz-Ruiz,* Manuel Caballero-
Martínez,* María Dolores Jiménez-Hernández . Trastorno alimentario relacionado con el sueño:
Una causa de obesidad. Revista de Endocrinología y Nutrición 2010;18(2):103-107
43. Allison KC, Lundgren JD, O´Reardon JP, et al. The Night eating questionnaire (NEQ):
Psychometric properties of a measure of severity of the eating syndrome. Eat Behav 2008; 9: 62-
72
44. Kucukgoncu S, Midura M, Tek C. Optimal management of night eating syndrome: challenges
and solutions. Neuropsychiatric Disease and Treatment. 2015;11:751-760.
45. O’Reardon JP, Stunkard AJ, Allison KC. Clinical trial of sertra- line in the treatment of night
eating syndrome. Int J Eat Disord. 2004;35(1):16
46. Stunkard AJ, Allison KC, Lundgren JD, et al. A paradigm for facilitating pharmacotherapy at a
distance: sertraline treatment of the night eating syndrome. J Clin Psychiatry. 2006;67(10):1568–
1572) (
47. Bodinat C, Guardiola-Lemaitre B, et al Agomelatine, the first melatonergic antidepressant: discovery,
characterization and development. Nat Rev Drug Discov. 2010;9(8):628–642.
48. Laudon M, Frydman-Marom A. Therapeutic effects of melatonin receptor agonists on sleep
and comorbid disorders. Int J Mol Sci. 2014;15(9):15924–15950.
49. Cooper-Kazaz R. Treatment of night eating syndrome with topiramate: dawn of a new day. J
Clin Psychopharmacol. 2012;32(1):143–145.
50. Tucker P, Masters B, Nawar O. Topiramate in the treatment of comorbid night eating
syndrome and PTSD: a case study. Eat Disord. 2004;12(1):75–78.),
51. Winkelman JW. Treatment of nocturnal eating syndrome and sleep-related eating disorder
with topiramate. Sleep Med. 2003;4(3):243–246.
52. Allison KC, Stunkard AJ, Thier SL. Overcoming night eating syndrome. Oakland, New
Harbinger Publications, 1era edición. 2004
53. Birketveldt. GS, Florholmrn J, et al A. Behavioral and neoroendocrine characteristics of the
nigh eating syndrome. JAMA. 1999; 282 (7): 657-663
54. Blomquist KK, Ansell EB, White MA, Masheb RM, Grilo CM. Interpersonal problems and
developmental trajectories of binge eating disorder. Compr Psychiatry. 2012;53(8):1088–95.
55. Sawaoka T, Barnes RD, Blomquist KK, Masheb RM, Grilo CM. Social anxiety and selfconsciousness
in binge eating disorder: associations with eating disorder psychopathology.
Compr.Psychiatry. 2012;53(6):740–5.
Cap. 8 PREVENCION
La obesidad se ha duplicado en los últimos 20 años, en adultos, niños y
adolescentes. Según OMS, la misma es del 62% la más alta en la región de las
Américas. (1). Como es una enfermedad multifactorial, relacionada a factores
inherentes a la persona y ambientales, que favorecen el almacenamiento de
35